Skip to main content

UBS Group AG

Position in BEAM — Beam Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in BEAM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$19,727,614
+$42,582 QoQ
Shares Held
574,814
-30.4% QoQ
Ownership
0.557%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 274 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in BEAM Over Time

Shares Held

Position Value (USD)

Derivatives in BEAM

reported options exposure · as of Mar 31, 2021
CallValue
$3,969,984
CallShares
49,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,365,122 across 562 Biotechnology names. BEAM ranks #83 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BEAM

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,727,614 574,814
2026-03-31 $19,685,032 826,061
2025-12-31 $26,994,926 973,843
2025-09-30 $27,610,351 1,137,633
2025-06-30 $19,797,834 1,163,894
2025-03-31 $28,548,735 1,461,789
2024-12-31 $45,126,971 1,819,636
2024-09-30 $4,635,252 189,194
2024-06-30 $3,809,176 162,577
2024-03-31 $8,267,961 250,241
2023-12-31 $7,090,809 260,500
2023-09-30 $2,871,521 119,398
2023-06-30 $4,061,687 127,206
2023-03-31 $1,631,586 53,285
2022-12-31 $5,424,752 138,705
2022-09-30 $388,693 8,159
2022-06-30 $1,531,057 39,552
2022-03-31 $3,767,933 65,758
2021-12-31 $3,074,758 38,584
2021-09-30 $4,241,824 48,751
2021-06-30 $3,728,728 28,970
2021-03-31 $3,083,860 38,529
2021-03-31 $3,969,984 49,600
2020-12-31 $1,776,159 21,756
2020-09-30 $109,829 4,461
2020-06-30 $202,580 7,235
2020-03-31 $14,400 800